Raymond Anton to Clinical Trials as Topic
This is a "connection" page, showing publications Raymond Anton has written about Clinical Trials as Topic.
Connection Strength
0.881
-
The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disorders. Neuropsychopharmacology. 2012 Jan; 37(2):402-11.
Score: 0.302
-
Design and analysis of trials of combination therapies. J Stud Alcohol Suppl. 2005 Jul; (15):34-42; discussion 33.
Score: 0.197
-
New methodologies for pharmacological treatment trials for alcohol dependence. Alcohol Clin Exp Res. 1996 Oct; 20(7 Suppl):3A-9A.
Score: 0.107
-
The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. Alcohol Clin Exp Res. 2012 Mar; 36(3):385-94.
Score: 0.075
-
Recent advances in the pharmacotherapy of alcoholism. Curr Psychiatry Rep. 2004 Oct; 6(5):332-8.
Score: 0.047
-
Current pharmacotherapies of alcoholism: a U.S. perspective. Am J Addict. 2003; 12(s1):s53-s68.
Score: 0.041
-
Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general population. Lancet Psychiatry. 2017 06; 4(6):469-476.
Score: 0.028
-
Pharmacotherapy of alcoholism--10 years of progress. Alcohol Clin Exp Res. 1996 Nov; 20(8 Suppl):172A-175A.
Score: 0.027
-
Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression. Am J Psychiatry. 1990 Sep; 147(9):1203-8.
Score: 0.018
-
Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry. 1989 May; 146(5):617-21.
Score: 0.016
-
Measurement and choice of drinking outcome variables in the COMBINE Study. J Stud Alcohol Suppl. 2005 Jul; (15):104-9; discussion 92-3.
Score: 0.012
-
Challenges to medications development in treating alcohol dependence: an international perspective. Alcohol Alcohol. 2004 Jul-Aug; 39(4):271-5.
Score: 0.011